These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis. Lewis GD; Witzke C; Colon-Hernandez P; Guerrero JL; Bloch KD; Semigran MJ J Am Coll Cardiol; 2006 Apr; 47(7):1471-7. PubMed ID: 16580539 [TBL] [Abstract][Full Text] [Related]
24. Role of platelet and vascular eicosanoids in the pathophysiology of ischemic heart disease. Chierchia S; Patrono C Fed Proc; 1987 Jan; 46(1):81-8. PubMed ID: 3542579 [TBL] [Abstract][Full Text] [Related]
25. [Pathogenetic importance of prostacyclin in atherosclerosis]. Efimov VV; Ladnyĭ AI Ter Arkh; 1985; 57(9):142-8. PubMed ID: 3909478 [No Abstract] [Full Text] [Related]
26. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Herbert JM; Dol F; Bernat A; Falotico R; Lalé A; Savi P Thromb Haemost; 1998 Sep; 80(3):512-8. PubMed ID: 9759636 [TBL] [Abstract][Full Text] [Related]
27. Effect of oral aspirin dose on platelet aggregation and arterial prostacyclin synthesis: studies in humans and rabbits. Ellis EF; Jones PS; Wright KF; Richardson DW; Ellis CK Adv Prostaglandin Thromboxane Res; 1980; 6():313-5. PubMed ID: 6770601 [No Abstract] [Full Text] [Related]
28. Correlation between bleeding time and antithrombotic effect of platelet-suppressive agents in rat experimental model. Suehiro A; Oura Y; Ueda M; Kakishita E Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):157-63. PubMed ID: 8202629 [TBL] [Abstract][Full Text] [Related]
29. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341 [TBL] [Abstract][Full Text] [Related]
30. Involvement of endogenous prostaglandin I2 in the vascular action of histamine in dogs. Toda N; Konishi M; Miyazaki M J Pharmacol Exp Ther; 1982 Oct; 223(1):257-62. PubMed ID: 6750081 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of arterial PGI2 generation and platelet aggregation by aspirin in rabbits ex vivo. Basista M Pol J Pharmacol Pharm; 1982; 34(5-6):317-21. PubMed ID: 6821216 [TBL] [Abstract][Full Text] [Related]
32. Aspirin and the prevention of thrombosis. J R Soc Health; 1993 Jun; 113(3):114. PubMed ID: 8320685 [No Abstract] [Full Text] [Related]
33. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Fletcher JR; Ramwell PW Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660 [TBL] [Abstract][Full Text] [Related]
34. [Aspirin as a platelet antiaggregant: indications and controversies]. Stalder M; Bachmann F Ther Umsch; 1987 Aug; 44(8):584-90. PubMed ID: 3313789 [No Abstract] [Full Text] [Related]
35. A new endocrine-like function of lungs: generation of prostacyclin. Gryglewski RJ; Korbut R; Spławiński J Mater Med Pol; 1978; 10(4):247-55. PubMed ID: 384098 [No Abstract] [Full Text] [Related]
36. Effects of aspirin in arterial thrombosis: why don't animals behave the way humans do? Mehta P; Mehta JL J Am Coll Cardiol; 1993 Feb; 21(2):511-3. PubMed ID: 8426018 [No Abstract] [Full Text] [Related]
38. Sex difference in antithrombotic effect of aspirin. Spranger M; Aspey BS; Harrison MJ Stroke; 1989 Jan; 20(1):34-7. PubMed ID: 2911832 [TBL] [Abstract][Full Text] [Related]
39. The aspirin dilemma revisited. N Engl J Med; 1984 May; 310(20):1326-7. PubMed ID: 6371528 [No Abstract] [Full Text] [Related]
40. On teaching an old dog new tricks. Vaisrub S JAMA; 1978 Nov; 240(21):2288. PubMed ID: 702759 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]